Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Oral steroid treatment for hearing improvement in Ménière's disease and endolymphatic hydrops.

Fisher LM, Derebery MJ, Friedman RA.

Otol Neurotol. 2012 Dec;33(9):1685-91. doi: 10.1097/MAO.0b013e31826dba83.

PMID:
23047260
2.

Hearing results of intratympanic steroid treatment of endolymphatic hydrops.

Arriaga MA, Goldman S.

Laryngoscope. 1998 Nov;108(11 Pt 1):1682-5.

PMID:
9818826
3.

Intratympanic steroids: do they acutely improve hearing in cases of cochlear hydrops?

Hillman TM, Arriaga MA, Chen DA.

Laryngoscope. 2003 Nov;113(11):1903-7.

PMID:
14603044
4.

Cochlear implantation in patients with bilateral Ménière's syndrome.

Lustig LR, Yeagle J, Niparko JK, Minor LB.

Otol Neurotol. 2003 May;24(3):397-403.

PMID:
12806291
5.

Summating potential and action potential ratio in Meniere's disease before and after treatment.

Orchik DJ, Shea JJ Jr, Ge NN.

Am J Otol. 1998 Jul;19(4):478-82; discussion 483.

PMID:
9661758
6.
7.

Endolymphatic hydrops in asymptomatic ears in unilateral Ménière's disease.

Friedrichs I, Thornton AR.

Laryngoscope. 2001 May;111(5):857-60.

PMID:
11359166
9.

Meniere's disease: prevalence of contralateral ear involvement.

House JW, Doherty JK, Fisher LM, Derebery MJ, Berliner KI.

Otol Neurotol. 2006 Apr;27(3):355-61.

PMID:
16639274
10.

Long-term results of endolymphatic sac drainage with local steroids for intractable Meniere's disease.

Kitahara T, Fukushima M, Uno A, Imai T, Ohta Y, Morihana T, Kamakura T, Horii A, Inohara H.

Auris Nasus Larynx. 2013 Oct;40(5):425-30. doi: 10.1016/j.anl.2012.11.008. Epub 2012 Dec 27.

PMID:
23273764
11.

Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.

Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W.

Otol Neurotol. 2005 Sep;26(5):890-5.

PMID:
16151334
12.

Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.

Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.

Otol Neurotol. 2010 Jun;31(4):649-55. doi: 10.1097/MAO.0b013e3181dd13ac.

PMID:
20431498
13.

Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.

Rajan GP, Din S, Atlas MD.

J Laryngol Otol. 2005 May;119(5):391-5.

PMID:
15949105
14.

Meniere's disease and endolymphatic hydrops without Meniere's symptoms: temporal bone histopathology.

Vasama JP, Linthicum FH Jr.

Acta Otolaryngol. 1999;119(3):297-301.

PMID:
10380731
15.

Unusual cases of delayed endolymphatic hydrops.

Albernaz PL.

Acta Otolaryngol. 2007 Apr;127(4):355-9.

PMID:
17453453
16.

In vivo visualized endolymphatic hydrops and inner ear functions in patients with electrocochleographically confirmed Ménière's disease.

Gürkov R, Flatz W, Louza J, Strupp M, Ertl-Wagner B, Krause E.

Otol Neurotol. 2012 Aug;33(6):1040-5. doi: 10.1097/MAO.0b013e31825d9a95.

PMID:
22772006
17.

Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops.

Magliulo G, Cianfrone G, Triches L, Altissimi G, D'Amico R.

Laryngoscope. 2001 Jan;111(1):102-9.

PMID:
11192876
18.

Cochlear microphonics in Ménière's disease.

Ge NN, Shea JJ Jr, Orchik DJ.

Am J Otol. 1997 Jan;18(1):58-66.

PMID:
8989953
19.
20.

Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease?

Junicho M, Aso S, Fujisaka M, Watanabe Y.

Acta Otolaryngol. 2008 Mar;128(3):304-8. doi: 10.1080/00016480601002096.

PMID:
18274917

Supplemental Content

Support Center